Related references
Note: Only part of the references are listed.ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study
I. Oschlies et al.
HAEMATOLOGICA (2012)
Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders
M. F. Benner et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group
Laurence Brugieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUCI cutaneous lymphocyte antigen negative
Marshall E. Kadin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Anaplastic large cell lymphoma in gingiva: case report and literature review
Naoyuki Matsumoto et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2008)
Prognostic factors in childhood anaplastic large cell lymphoma:: results of a large European intergroup study
Marie-Cecile Le Deley et al.
BLOOD (2008)
Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation:: a genetic and pathological correlation
SL Perkins et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence
B Burkhardt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Three children with CD30+ cutaneous anaplastic large cell lymphomas bearing the t(2;5)(p23;q35) translocation
M Hinshaw et al.
PEDIATRIC DERMATOLOGY (2004)
A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation
K Sasaki et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects - a review
RL ten Berge et al.
JOURNAL OF PATHOLOGY (2003)
MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form
RL ten Berge et al.
JOURNAL OF CLINICAL PATHOLOGY (2001)
CD30+lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis
M Aoki et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)